Oppenheimer Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Oppenheimer Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,034	Closed	-$331K	–	1189
2022 Q4	$331K	Sell	9,034 -8,810	-49%	-$348K	0.01%	944
2022 Q3	$842K	Buy	17,844 +545	+3%	+$35.2K	0.01%	707
2022 Q2	$1.24M	Buy	17,299 +337	+2%	+$24.6K	0.02%	608
2022 Q1	$1.37M	Sell	16,962 -3,046	-15%	-$258K	0.02%	648
2021 Q4	$2.05M	Sell	20,008 -4,770	-19%	-$458K	0.03%	542
2021 Q3	$2.17M	Sell	24,778 -881	-3%	-$79.7K	0.03%	514
2021 Q2	$2.3M	Buy	25,659 +4,796	+23%	+$405K	0.03%	485
2021 Q1	$1.58M	Buy	20,863 +1,311	+7%	+$98.8K	0.02%	582
2020 Q4	$1.33M	Buy	19,552 +5,109	+35%	+$319K	0.02%	597
2020 Q3	$768K	Buy	14,443 +2,310	+19%	+$138K	0.01%	693
2020 Q2	$706K	Buy	12,133 +8,310	+217%	+$447K	0.01%	698
2020 Q1	$151K	Sell	3,823 -210	-5%	-$12.3K	﹤0.01%	1022
2019 Q4	$240K	Buy	4,033 +369	+10%	+$19.8K	0.01%	1020
2019 Q3	$195K	Buy	3,664 +350	+11%	+$18K	﹤0.01%	1040
2019 Q2	$170K	Buy	3,314 +1,510	+84%	+$70.3K	﹤0.01%	1083
2019 Q1	$93K	Buy	1,804 +129	+8%	+$6.25K	﹤0.01%	1232
2018 Q4	$66K	Buy	+1,675	New	+$77.8K	﹤0.01%	1295
2017 Q4	–	Sell	-1,355	Closed	-$71K	–	1537
2017 Q3	$71K	Buy	1,355 +14	+1%	+$781	﹤0.01%	1279
2017 Q2	$78K	Buy	1,341 +19	+1%	+$987	﹤0.01%	1254
2017 Q1	$61K	Buy	+1,322	New	+$65.8K	﹤0.01%	1297

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Oppenheimer Asset Management's SYNH Position: Q1 2023 in Review

Oppenheimer Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 9,034 shares — an estimated $331K sold.

Oppenheimer Asset Management first reported a position in SYNH in Q1 2017 and held it in 20 quarters. The position peaked at $2.3M in Q2 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Oppenheimer Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Oppenheimer Asset Management sold 9,034 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $331K.
Oppenheimer Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 20 quarters.
Oppenheimer Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $2.3M in Q2 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Oppenheimer Asset Management's 13F filing for Q1 2023, filed 10 May 2023.